Related Experiment Video
Updated: Jan 7, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Bacterıal pathogens ın ventılator-assocıated pneumonıa; molecular assessment of resıstance profıles
Besim Çam1, Lokman Hi̇zmali̇2,3, Elif Sevi̇m4,5
1Graduate School of Health Sciences, Hospıtal Infectıon Control, Kırşehir Ahi Evran University, Kırşehir, Turkey.
Abstract:
Ventilator-associated pneumonia (VAP) is the most common infection encountered in intensive care units and is closely linked with elevated mortality, morbidity, and healthcare expenditure. The predominant pathogens responsible for VAP are multidrug-resistant (MDR) Gram-negative bacteria, including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli. This study aimed to investigate the molecular antibiotic resistance profiles of bacterial isolates from hospital-acquired VAP cases. Conducted between 30 November 2022 and 30 November 2023 at Kırşehir Training and Research Hospital, resistance genes were identified using Polymerase Chain Reaction (PCR), while clonal relatedness and genotyping were assessed through Repetitive Extragenic Palindromic-PCR (rep-PCR) and Multi-Locus Sequence Typing (MLST). The most frequently isolated organisms were A. baumannii (46.2%), K. pneumoniae (42.3%), and P. aeruginosa (7.7%). A. baumannii strains exhibited 100% resistance to ciprofloxacin and carbapenems, and 70.83% to colistin. K. pneumoniae strains demonstrated 94.73% resistance to carbapenems and 100% to piperacillin-tazobactam and colistin. Molecular analyses identified blaTEM, blaOXA-1, blaCTX-M1, blaOXA-51, blaOXA-23, and blaOXA-40 in A. baumannii, and blaTEM, blaSHV, blaCTX-M1, blaOXA-1, blaOXA-48, and blaNDM-1 in K. pneumoniae. Nine isolates (17%) were identified as transconjugants. MLST analysis revealed K. pneumoniae ST2096 and A. baumannii ST2 as predominant. Clones not previously reported in Türkiye A. baumannii ST78 and K. pneumoniae ST45, ST437, and ST1128 were also detected. This study provides a comprehensive molecular characterisation of VAP pathogens based on an extensive dataset. The results underscore the need for stricter infection control, restrained use of broad-spectrum antibiotics, and ongoing surveillance of resistance mechanisms.
Insights
Ventilator-associated pneumonia (VAP) is a critical ICU infection. This study identified multidrug-resistant Gram-negative bacteria, revealing high resistance to carbapenems and colistin, necessitating enhanced infection control.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Research
Background:
- Ventilator-associated pneumonia (VAP) is a leading cause of intensive care unit infections, associated with increased mortality and healthcare costs.
- Multidrug-resistant (MDR) Gram-negative bacteria, including Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa, are the primary VAP pathogens.
- Understanding the molecular resistance mechanisms of these pathogens is crucial for effective treatment and control.
Purpose of the Study:
- To investigate the molecular antibiotic resistance profiles of bacterial isolates from hospital-acquired VAP cases.
- To identify specific resistance genes and characterize the genetic relatedness of VAP pathogens.
- To provide a comprehensive molecular characterization of VAP pathogens in a Turkish hospital setting.
Main Methods:
- Bacterial isolates from VAP cases were collected over one year at Kırşehir Training and Research Hospital.
- Polymerase Chain Reaction (PCR) was used to identify antibiotic resistance genes.
- Repetitive Extragenic Palindromic-PCR (rep-PCR) and Multi-Locus Sequence Typing (MLST) were employed for genotyping and assessing clonal relatedness.
Main Results:
- Acinetobacter baumannii (46.2%) and Klebsiella pneumoniae (42.3%) were the most frequent isolates.
- High resistance rates were observed: A. baumannii showed 100% resistance to ciprofloxacin and carbapenems; K. pneumoniae exhibited 94.73% resistance to carbapenems and 100% to colistin.
- Specific resistance genes (e.g., blaTEM, blaOXA-23, blaNDM-1) were identified, and predominant MLST types (e.g., A. baumannii ST2, K. pneumoniae ST2096) were determined, including novel clones in Türkiye.
Conclusions:
- The study highlights a significant burden of MDR Gram-negative bacteria causing VAP, with concerning resistance to critical antibiotics like carbapenems and colistin.
- Molecular characterization revealed specific resistance genes and prevalent bacterial clones, including novel ones in Türkiye.
- Findings emphasize the urgent need for enhanced infection control measures, judicious antibiotic use, and continuous surveillance of antimicrobial resistance mechanisms in VAP.
More Related Videos
06:11Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012